Specifically, triptolide reduces TAM infiltration in colon cancer (HT-29 and CT26) cells by down-regulating CXCL12 gene and protein expression via the NF-κB-ERK1/2 signaling axis, while delaying M2 polarization. This evidence concerns the gene NFKB1 and colonic neoplasm.